BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2879850)

  • 41. Mesoprefrontal cortical dopaminergic activity and prefrontal hypofunction in schizophrenia.
    Weinberger DR; Berman KF; Daniel DG
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():568A-569A. PubMed ID: 1498953
    [No Abstract]   [Full Text] [Related]  

  • 42. Letter: Mental activity and cerebral blood-flow.
    Trethewie ER
    Lancet; 1974 May; 1(7863):939. PubMed ID: 4133472
    [No Abstract]   [Full Text] [Related]  

  • 43. Correlations between abnormal hippocampal morphology and prefrontal physiology in schizophrenia.
    Weinberger DR; Berman KF; Torrey EF
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():393A-394A. PubMed ID: 1498889
    [No Abstract]   [Full Text] [Related]  

  • 44. Dopaminergic insufficiency reflecting cerebral ageing: value of a dopaminergic agonist, piribedil.
    Ollat H
    J Neurol; 1992; 239 Suppl 1():S13-6. PubMed ID: 1634905
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hypofrontality in schizophrenia.
    Jones BD
    Can J Psychiatry; 1988 Apr; 33(3):243-5. PubMed ID: 2898284
    [No Abstract]   [Full Text] [Related]  

  • 46. Abnormalities of cerebral blood flow distribution in patients with chronic schizophrenia.
    Ingvar DH; Franzén G
    Acta Psychiatr Scand; 1974; 50(4):425-62. PubMed ID: 4423855
    [No Abstract]   [Full Text] [Related]  

  • 47. Neural plasticity in schizophrenia.
    Haracz JL
    Schizophr Bull; 1985; 11(2):191-229. PubMed ID: 4012226
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Regional cerebral blood flow in schizophrenia: a preliminary report.
    Mathew RJ; Meyer JS; Francis DJ; Schoolar JC; Weinman M; Mortel KF
    Am J Psychiatry; 1981 Jan; 138(1):112-3. PubMed ID: 7446762
    [No Abstract]   [Full Text] [Related]  

  • 49. Frontal-lobe hypofunction in schizophrenia.
    Lancet; 1984 Apr; 1(8383):969-71. PubMed ID: 6143911
    [No Abstract]   [Full Text] [Related]  

  • 50. Affect as a neurobehavioural probe in the evaluation of hypofrontality.
    Ramasubbu R
    Br J Psychiatry; 1993 Aug; 163():260-1. PubMed ID: 8075920
    [No Abstract]   [Full Text] [Related]  

  • 51. Cerebral blood flow in schizophrenia.
    Prohovnik I; Sackeim HA; Malitz S; Decina P
    Arch Gen Psychiatry; 1983 Jul; 40(7):811-2. PubMed ID: 6860081
    [No Abstract]   [Full Text] [Related]  

  • 52. Neural models of schizophrenia.
    Heckers S
    Dialogues Clin Neurosci; 2000 Sep; 2(3):267-79. PubMed ID: 22033839
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Deletion of the STOP gene, a microtubule stabilizing factor, leads only to discrete cerebral metabolic changes in mice.
    Hanaya R; Koning E; Ferrandon A; Schweitzer A; Andrieux A; Nehlig A
    J Neurosci Res; 2008 Mar; 86(4):813-20. PubMed ID: 17969102
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of a structural polymorphism in the ankyrin repeat and kinase domain containing 1 (ANKK1) gene and the activation of executive attention networks.
    Fossella J; Green AE; Fan J
    Cogn Affect Behav Neurosci; 2006 Mar; 6(1):71-8. PubMed ID: 16869231
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Desipramine attenuates working memory impairments induced by partial loss of catecholamines in the rat medial prefrontal cortex.
    Clinton SM; Sucharski IL; Finlay JM
    Psychopharmacology (Berl); 2006 Jan; 183(4):404-12. PubMed ID: 16307295
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessing the molecular genetics of attention networks.
    Fossella J; Sommer T; Fan J; Wu Y; Swanson JM; Pfaff DW; Posner MI
    BMC Neurosci; 2002 Oct; 3():14. PubMed ID: 12366871
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Functional brain mapping of psychopathology.
    Honey GD; Fletcher PC; Bullmore ET
    J Neurol Neurosurg Psychiatry; 2002 Apr; 72(4):432-9. PubMed ID: 11909899
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Functional neuroimaging in psychiatry.
    Fu CH; McGuire PK
    Philos Trans R Soc Lond B Biol Sci; 1999 Jul; 354(1387):1359-70. PubMed ID: 10466156
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reversibility of hemodynamic hypofrontality in schizophrenia.
    Geraud G; Arné-Bès MC; Güell A; Bes A
    J Cereb Blood Flow Metab; 1987 Feb; 7(1):9-12. PubMed ID: 2879850
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of age, neuropsychological impairment, and medication on regional cerebral blood flow in schizophrenia and major affective disorder.
    Goldstein PC; Brown GG; Marcus A; Ewing JR
    Henry Ford Hosp Med J; 1990; 38(4):202-6. PubMed ID: 1982284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.